ascopubs.org17d
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
Erratum: ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma The German CLL Study Group conducted a ...
ascopubs.org9d
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA The ESPAC4 trial showed that ...
ascopubs.org7d
Development and Validation of Dynamic 5-Year Breast Cancer Risk Model Using Repeated Mammograms
Current image-based long-term risk prediction models do not fully use previous screening mammogram images. Dynamic prediction models have not been investigated for use in routine care. We analyzed a ...
ascopubs.org9d
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy
KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers Malignant phyllodes tumors (MPTs) are rare fibroepithelial tumors of the breast with aggressive ...
ascopubs.org9d
INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases
This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to ...
ascopubs.org9d
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening Cohort
Parents' Experiences With and Preferences for Receiving Information About Tumor Genomic Sequencing: Findings From a Qualitative Study and Implications for Practice The National Cancer ...
ascopubs.org17d
Understanding Hope and Debunking Its Myths Forge a Valuable Tool for Clinicians
A 64-year-old engineer was diagnosed with a cT2cN0M0, Gleason score 8, adenocarcinoma of the prostate. His prostate-specific antigen level was 15 ng/mL. The case was discussed at the hospital tumor ...
ascopubs.org10d
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial
We conducted a prospective, randomized, multicenter trial examining short-course adjuvant VCB (11 Gy × two fractions at the surface) compared with standard regimens (7 Gy × three fractions at 0.5 cm ...
ascopubs.org12d
Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review
A total of 18,530 reports were identified, of which 41 met review criteria and were analyzed. Included studies were predominantly published between 2021 and 2023, originated in the United States (39.0 ...
ascopubs.org6d
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen ...
ascopubs.org12d
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database
Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study The marked underrepresentation of ...